Valuation: Zai Lab Limited

Market Cap 296.83Cr 260.53Cr 244.9Cr 223.9Cr 418.4Cr 28TCr 421.5Cr 2.94TCr 1.14TCr 14TCr 1.11TCr 1.09TCr 47TCr P/E 2026 *
-12x
P/E 2027 * -11.9x
Enterprise Value 251.07Cr 220.36Cr 207.14Cr 189.38Cr 353.89Cr 24TCr 356.51Cr 2.49TCr 964.55Cr 12TCr 942.83Cr 922.17Cr 40TCr EV / Sales 2026 *
5.75x
EV / Sales 2027 * 4.69x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.11%
1 week+7.17%
Current month+3.85%
1 month+1.65%
3 months+43.00%
6 months+50.14%
Current year+49.89%
1 week 25.6
Extreme 25.6
27.14
1 month 23.64
Extreme 23.64
27.5
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
34.72
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
119.16
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/08/26 Sell

Chief Financial Officer

-260 0.0000%
14/08/26 Exercice

Chief Financial Officer

2,927 0.0003%
12/08/26 Other

Director

-85,060 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+7.17%-17.56%+8.05% 296.5Cr
-0.26%+3.51%+41.19%-2.79% 8.03TCr
-0.25%+25.06%+606.13%+82.13% 7.29TCr
-0.13%+0.81%-9.30%-29.25% 6.15TCr
-1.80%-3.05%-14.24%+26.38% 4.74TCr
-0.89%+2.67%+3.52%+157.67% 4.66TCr
+0.96%+5.33%+63.33%-11.70% 3.33TCr
-1.80%-0.09%+47.43%+114.53% 2.57TCr
-2.71%+4.63%+5.84%+157.95% 2.29TCr
-1.92%+0.05%+57.90%+100.00% 1.58TCr
Average -0.96%+5.57%+78.42%+60.30% 4.09TCr
Weighted average by Cap. -0.85%+6.80%+123.93%+49.68%

Financials

2026 *2027 *
Net sales 44Cr 38Cr 36Cr 33Cr 62Cr 4.18TCr 62Cr 432.54Cr 167.68Cr 2.13TCr 163.91Cr 160.32Cr 6.91TCr 55Cr 48Cr 46Cr 42Cr 78Cr 5.29TCr 78Cr 547.16Cr 212.12Cr 2.7TCr 207.34Cr 202.8Cr 8.74TCr
Net income -24Cr -21Cr -20Cr -18Cr -34Cr -2.31TCr -34Cr -238.5Cr -92Cr -1.18TCr -90Cr -88Cr -3.81TCr -21Cr -19Cr -17Cr -16Cr -30Cr -2.02TCr -30Cr -209.18Cr -81Cr -1.03TCr -79Cr -78Cr -3.34TCr
Net Debt -46Cr -40Cr -38Cr -35Cr -65Cr -4.38TCr -65Cr -453.53Cr -175.82Cr -2.24TCr -171.86Cr -168.1Cr -7.25TCr -38Cr -33Cr -31Cr -29Cr -54Cr -3.65TCr -54Cr -377.39Cr -146.3Cr -1.86TCr -143.01Cr -139.87Cr -6.03TCr
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
23/26/23 $26.44 +0.11% 7,91,634
22/26/22 $26.41 -0.08% 9,96,561
21/26/21 $26.43 +2.84% 11,82,035
18/26/18 $25.70 -0.43% 8,87,484
17/26/17 $25.81 +4.62% 6,73,110
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.44USD
Average target price
33.14USD
Spread / Average Target
+25.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock